Albert Labs has appointed Professor Robert Britton and Dr Ricardo Jorge Dinis-Oliveira to its scientific advisory board (SAB).
The Shift Network is presenting the Psychedelic Healing Summit — a free, four-day online event featuring leading voices in the field of psychedelics.
The philanthropic arm of atai Life Sciences, atai Impact, has donated $500,000 to The Multidisciplinary Association for Psychedelics (MAPS) for multi-year support of MAPS’ ongoing initiatives,...
The thematic ETF will track the performance of the Enhanced Consciousness Index – comprised of companies involved in the legal research, development and production of psychedelics...
Leafy Tunnel’s USD$30m (~£22.38m) fund focuses on global psychedelics opportunities alongside European medical cannabis opportunities.
UK-based psychedelics company Albert Labs has received conditional approval for the listing of its common shares on the Canadian Securities Exchange (CSE).
Leaders in the fields of psychedelics and cannabis will join together for the GCI Virtual Summit.
Sports luminaries including Mike Tyson will be among the world-leading speakers headlining the largest psychedelic medicine business conference next month.
Origin Therapeutics is poising for public listing on the Canadian Securities Exchange (CSE).
The End in Mind conference will bring together celebrities, healthcare and psychedelics experts and policy makers to explore the role that psychedelics can play in the...